Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Bioorg Med Chem Lett ; 72: 128879, 2022 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-35809818

RESUMEN

The N-demethylation of zicronapine (7) and three of its deuterated analogs 8 - 10 has been studied in human in vitro metabolism systems. While the N-deuterio-methyl analog 8 did not behave differently from the parent in human liver microsomes, a significantly reduced rate of N-demethylation was observed as a consequence of benzene ring deuteration (compound 7vs.9). Additional deuteration of the N-methyl group, which as mentioned had shown no effect in isolation, further decreased the rate of the N-demethylation reaction (compound 10vs.9). This paper presents and discusses this unprecedented 'distal kinetic isotope effect' that was observed when incubating the test compounds with human liver microsomes or recombinant human CYP450 liver enzymes.


Asunto(s)
Sistema Enzimático del Citocromo P-450 , Microsomas Hepáticos , Sistema Enzimático del Citocromo P-450/metabolismo , Desmetilación , Deuterio/metabolismo , Humanos , Cinética , Microsomas Hepáticos/metabolismo
2.
Expert Opin Drug Metab Toxicol ; 13(7): 767-782, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28604124

RESUMEN

INTRODUCTION: The liver is an important target for drug-induced toxicities. Early detection of hepatotoxic drugs requires use of well-characterized test systems, yet current knowledge, gaps and limitations of tests employed remains an important issue for drug development. Areas Covered: The current state of the science, understanding and application of test systems in use for the detection of drug-induced cytotoxicity, mitochondrial toxicity, cholestasis and inflammation is summarized. The test systems highlighted herein cover mostly in vitro and some in vivo models and endpoint measurements used in the assessment of small molecule toxic liabilities. Opportunities for research efforts in areas necessitating the development of specific tests and improved mechanistic understanding are highlighted. Expert Opinion: Use of in vitro test systems for safety optimization will remain a core activity in drug discovery. Substantial inroads have been made with a number of assays established for human Drug-induced Liver Injury. There nevertheless remain significant gaps with a need for improved in vitro tools and novel tests to address specific mechanisms of human Drug-Induced Liver Injury. Progress in these areas will necessitate not only models fit for application, but also mechanistic understanding of how chemical insult on the liver occurs in order to identify translational and quantifiable readouts for decision-making.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Descubrimiento de Drogas/métodos , Pruebas de Toxicidad/métodos , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/fisiopatología , Diseño de Fármacos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/diagnóstico , Humanos , Modelos Biológicos , Medición de Riesgo/métodos
3.
Nucl Med Biol ; 31(3): 327-36, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15028245

RESUMEN

Central alpha(1)-adrenergic receptors are potential targets for recently developed antipsychotic drugs. Two new 11C labeled potent and selective alpha(1)-adrenoceptor antagonists, 1- [2- [4-[1-(4-fluorophenyl)-5-(2-[(11)C]methyl-tetrazol-5-yl)-1H-indol-3-yl]-1-piperidinyl]ethyl]-imidazolidin-2-one ([(11)C]2) and 1- [2- [4-[1-(4-fluorophenyl)-5-(1-[(11)C]methyl-(1,2,3-triazol-4-yl)-1H-indol-3-yl]-1-piperidinyl]ethyl]-imidazolidin-2-one ([(11)C]3) were prepared and evaluated for imaging of central alpha(1)-adrenergic receptors in the cynomolgus monkey brain. For both compounds, the total brain radioactivity was only about 0.6% of the radioactivity injected i.v. There was no evident binding in regions known to contain alpha(1)-adrenoceptors. This observation suggests that the affinity of the radioligands in primates in vivo is not sufficient to provide a signal for specific binding that can be differentiated from the background. In addition, active efflux by P-glycoprotein may be responsible for the low total brain-uptake of the two radioligands. Both compounds showed a highly polarised and verapamile sensitive transport across monolayers of Caco-2 cells. The total brain-uptake of [(3)H]2 was 6 times higher in mdr1a(-/-) knock-out mice lacking the gene encoding P-glycoprotein compared to wild type mice. Pretreatment of one monkey with Cyclosporin A (15 mg/kg) resulted in 40% higher brain uptake for [(11)C]3 when compared with baseline. These observations support the view that efflux by P-glycoprotein can be of quantitative importance for the total brain-uptake of some PET radioligands.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 1 , Encéfalo/diagnóstico por imagen , Encéfalo/metabolismo , Imidazoles/farmacocinética , Indoles/farmacocinética , Receptores Adrenérgicos alfa 1/metabolismo , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/deficiencia , Animales , Antipsicóticos/química , Antipsicóticos/farmacocinética , Encéfalo/efectos de los fármacos , Células CACO-2 , Radioisótopos de Carbono/química , Radioisótopos de Carbono/farmacocinética , Ciclosporina/farmacología , Evaluación Preclínica de Medicamentos , Humanos , Imidazoles/química , Indoles/química , Marcaje Isotópico/métodos , Cinética , Macaca fascicularis , Masculino , Tasa de Depuración Metabólica , Ratones , Tomografía de Emisión de Positrones/métodos , Unión Proteica , Radiofármacos/síntesis química , Radiofármacos/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA